Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0115 Transporter Info | ||||
Gene Name | SLC17A2 | ||||
Transporter Name | Sodium-dependent phosphate transport protein 3 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Pancretic ductal adenocarcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC17A2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg09125430) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 6.08E+00 | Statistic Test | p-value: 4.38E-40; Z-score: 1.73E+01 | ||
Methylation in Case |
3.80E-01 (Median) | Methylation in Control | 6.24E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC17A2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg23702688) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.19E+00 | Statistic Test | p-value: 6.19E-05; Z-score: -1.12E+00 | ||
Methylation in Case |
2.60E-01 (Median) | Methylation in Control | 3.10E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC17A2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg19016972) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.16E+00 | Statistic Test | p-value: 1.30E-09; Z-score: -1.94E+00 | ||
Methylation in Case |
7.12E-01 (Median) | Methylation in Control | 8.24E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC17A2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg20955989) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 4.53E-06; Z-score: 8.35E-01 | ||
Methylation in Case |
3.46E-01 (Median) | Methylation in Control | 2.84E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC17A2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg23745839) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.19E+00 | Statistic Test | p-value: 4.30E-05; Z-score: 6.85E-01 | ||
Methylation in Case |
2.37E-01 (Median) | Methylation in Control | 1.99E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC17A2 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg20765441) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.37E+00 | Statistic Test | p-value: 5.50E-06; Z-score: -3.95E+00 | ||
Methylation in Case |
4.55E-01 (Median) | Methylation in Control | 6.23E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC17A2 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg09546929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.25E+00 | Statistic Test | p-value: 9.17E-14; Z-score: -1.88E+01 | ||
Methylation in Case |
3.76E-01 (Median) | Methylation in Control | 8.46E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC17A2 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg01382804) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.53E+00 | Statistic Test | p-value: 2.84E-13; Z-score: -1.41E+01 | ||
Methylation in Case |
3.34E-01 (Median) | Methylation in Control | 8.43E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC17A2 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg20373747) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.22E+00 | Statistic Test | p-value: 3.15E-12; Z-score: -1.07E+02 | ||
Methylation in Case |
3.83E-01 (Median) | Methylation in Control | 8.49E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC17A2 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg04867634) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.89E+00 | Statistic Test | p-value: 2.52E-11; Z-score: -3.52E+01 | ||
Methylation in Case |
4.77E-01 (Median) | Methylation in Control | 9.01E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC17A2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg08278435) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.26E+00 | Statistic Test | p-value: 1.73E-03; Z-score: -4.60E+00 | ||
Methylation in Case |
5.88E-01 (Median) | Methylation in Control | 7.43E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC17A2 in bladder cancer | [ 2 ] | |||
Location |
3'UTR (cg27312087) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 2.22E-05; Z-score: 4.76E+00 | ||
Methylation in Case |
8.40E-01 (Median) | Methylation in Control | 6.76E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC17A2 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg20765441) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.19E+00 | Statistic Test | p-value: 6.48E-08; Z-score: -1.84E+00 | ||
Methylation in Case |
5.51E-01 (Median) | Methylation in Control | 6.54E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC17A2 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg01936555) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.01E-03; Z-score: -6.21E-01 | ||
Methylation in Case |
9.08E-01 (Median) | Methylation in Control | 9.16E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC17A2 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg09546929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 1.94E-08; Z-score: -1.59E+00 | ||
Methylation in Case |
7.93E-01 (Median) | Methylation in Control | 8.60E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC17A2 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg01382804) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 8.97E-06; Z-score: -1.28E+00 | ||
Methylation in Case |
8.19E-01 (Median) | Methylation in Control | 8.61E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC17A2 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg20373747) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 2.31E-04; Z-score: -1.21E+00 | ||
Methylation in Case |
8.14E-01 (Median) | Methylation in Control | 8.75E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC17A2 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg04867634) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 8.03E-04; Z-score: -5.27E-01 | ||
Methylation in Case |
9.05E-01 (Median) | Methylation in Control | 9.11E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC17A2 in breast cancer | [ 3 ] | |||
Location |
Body (cg08278435) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.19E+00 | Statistic Test | p-value: 1.47E-13; Z-score: -3.27E+00 | ||
Methylation in Case |
6.99E-01 (Median) | Methylation in Control | 8.30E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC17A2 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg20765441) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.25E+00 | Statistic Test | p-value: 3.30E-06; Z-score: -1.68E+00 | ||
Methylation in Case |
5.36E-01 (Median) | Methylation in Control | 6.69E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC17A2 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg24163360) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 2.53E-02; Z-score: -5.02E-01 | ||
Methylation in Case |
8.02E-01 (Median) | Methylation in Control | 8.48E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC17A2 in colorectal cancer | [ 4 ] | |||
Location |
TSS200 (cg20373747) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 7.17E-04; Z-score: -6.82E-01 | ||
Methylation in Case |
9.40E-01 (Median) | Methylation in Control | 9.48E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC17A2 in colorectal cancer | [ 4 ] | |||
Location |
TSS200 (cg09546929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 9.64E-04; Z-score: -9.53E-01 | ||
Methylation in Case |
8.96E-01 (Median) | Methylation in Control | 9.16E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC17A2 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg08278435) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 4.34E-10; Z-score: -3.10E+00 | ||
Methylation in Case |
7.95E-01 (Median) | Methylation in Control | 8.94E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC17A2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg24163360) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.26E+00 | Statistic Test | p-value: 6.49E-04; Z-score: -8.29E-01 | ||
Methylation in Case |
3.64E-01 (Median) | Methylation in Control | 4.58E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC17A2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg20765441) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.23E+00 | Statistic Test | p-value: 1.68E-03; Z-score: -9.59E-01 | ||
Methylation in Case |
2.44E-01 (Median) | Methylation in Control | 3.00E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC17A2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg01936555) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 1.80E-02; Z-score: -5.25E-01 | ||
Methylation in Case |
6.35E-01 (Median) | Methylation in Control | 7.06E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC17A2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS200 (cg20373747) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.28E+00 | Statistic Test | p-value: 5.80E-09; Z-score: -1.29E+00 | ||
Methylation in Case |
4.58E-01 (Median) | Methylation in Control | 5.85E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC17A2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS200 (cg04867634) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.34E+00 | Statistic Test | p-value: 2.01E-08; Z-score: -1.44E+00 | ||
Methylation in Case |
4.60E-01 (Median) | Methylation in Control | 6.15E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC17A2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS200 (cg01382804) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.40E+00 | Statistic Test | p-value: 3.61E-08; Z-score: -1.24E+00 | ||
Methylation in Case |
4.00E-01 (Median) | Methylation in Control | 5.60E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC17A2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS200 (cg09546929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.33E+00 | Statistic Test | p-value: 1.63E-07; Z-score: -1.17E+00 | ||
Methylation in Case |
4.31E-01 (Median) | Methylation in Control | 5.72E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC17A2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg12913587) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.44E+00 | Statistic Test | p-value: 4.24E-15; Z-score: -5.29E+00 | ||
Methylation in Case |
5.84E-01 (Median) | Methylation in Control | 8.42E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC17A2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg07834249) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.30E+00 | Statistic Test | p-value: 3.40E-12; Z-score: -7.62E+00 | ||
Methylation in Case |
6.29E-01 (Median) | Methylation in Control | 8.18E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC17A2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg08278435) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 9.20E-04; Z-score: 5.67E-01 | ||
Methylation in Case |
8.37E-01 (Median) | Methylation in Control | 8.11E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC17A2 in HIV infection | [ 6 ] | |||
Location |
TSS1500 (cg24163360) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 8.72E-03; Z-score: -2.16E-01 | ||
Methylation in Case |
9.17E-01 (Median) | Methylation in Control | 9.24E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC17A2 in HIV infection | [ 6 ] | |||
Location |
TSS200 (cg09546929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.13E-02; Z-score: -8.88E-01 | ||
Methylation in Case |
9.13E-01 (Median) | Methylation in Control | 9.31E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC17A2 in HIV infection | [ 6 ] | |||
Location |
TSS200 (cg01382804) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.57E-02; Z-score: -5.11E-01 | ||
Methylation in Case |
9.29E-01 (Median) | Methylation in Control | 9.40E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC17A2 in HIV infection | [ 6 ] | |||
Location |
Body (cg08278435) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 7.08E-06; Z-score: -2.43E+00 | ||
Methylation in Case |
8.10E-01 (Median) | Methylation in Control | 8.79E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC17A2 in papillary thyroid cancer | [ 7 ] | |||
Location |
TSS1500 (cg20765441) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 8.32E-04; Z-score: -6.85E-01 | ||
Methylation in Case |
7.98E-01 (Median) | Methylation in Control | 8.25E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC17A2 in papillary thyroid cancer | [ 7 ] | |||
Location |
TSS1500 (cg01936555) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 6.03E-03; Z-score: -5.14E-01 | ||
Methylation in Case |
9.41E-01 (Median) | Methylation in Control | 9.48E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC17A2 in papillary thyroid cancer | [ 7 ] | |||
Location |
TSS1500 (cg24163360) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.01E-02; Z-score: -7.42E-01 | ||
Methylation in Case |
9.05E-01 (Median) | Methylation in Control | 9.26E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC17A2 in papillary thyroid cancer | [ 7 ] | |||
Location |
Body (cg08278435) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 2.04E-02; Z-score: -1.40E-01 | ||
Methylation in Case |
9.00E-01 (Median) | Methylation in Control | 9.05E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC17A2 in papillary thyroid cancer | [ 7 ] | |||
Location |
3'UTR (cg27312087) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 3.22E-02; Z-score: -1.32E-01 | ||
Methylation in Case |
8.88E-01 (Median) | Methylation in Control | 8.91E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC17A2 in prostate cancer | [ 8 ] | |||
Location |
TSS1500 (cg06689659) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 4.30E-02; Z-score: 1.51E+00 | ||
Methylation in Case |
9.42E-01 (Median) | Methylation in Control | 9.23E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC17A2 in prostate cancer | [ 8 ] | |||
Location |
TSS200 (cg27645955) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 7.71E+00 | Statistic Test | p-value: 1.13E-02; Z-score: 2.67E+01 | ||
Methylation in Case |
3.53E-01 (Median) | Methylation in Control | 4.58E-02 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC17A2 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS200 (cg04867634) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.05E-02; Z-score: 1.61E+00 | ||
Methylation in Case |
9.02E-01 (Median) | Methylation in Control | 8.47E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC17A2 in lung adenocarcinoma | [ 9 ] | |||
Location |
Body (cg08278435) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 2.51E-02; Z-score: -1.42E+00 | ||
Methylation in Case |
7.46E-01 (Median) | Methylation in Control | 8.08E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC17A2 in panic disorder | [ 10 ] | |||
Location |
TSS200 (cg09546929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 4.91E-04; Z-score: 6.05E-01 | ||
Methylation in Case |
2.55E+00 (Median) | Methylation in Control | 2.42E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC17A2 in panic disorder | [ 10 ] | |||
Location |
TSS200 (cg01382804) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.82E-02; Z-score: 5.18E-01 | ||
Methylation in Case |
2.33E+00 (Median) | Methylation in Control | 2.19E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC17A2 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg08278435) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 5.67E-03; Z-score: -6.97E-01 | ||
Methylation in Case |
8.13E-01 (Median) | Methylation in Control | 8.63E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC17A2 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
3'UTR (cg27312087) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.73E+00 | Statistic Test | p-value: 3.38E-09; Z-score: -1.77E+00 | ||
Methylation in Case |
2.23E-01 (Median) | Methylation in Control | 3.87E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Depression |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC17A2 in depression | [ 12 ] | |||
Location |
Body (cg08278435) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.98E-02; Z-score: -3.27E-01 | ||
Methylation in Case |
7.95E-01 (Median) | Methylation in Control | 8.03E-01 (Median) | ||
Studied Phenotype |
Depression [ ICD-11: 6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-335 directly targets SLC17A2 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-335 | miRNA Mature ID | miR-335-5p | ||
miRNA Sequence |
UCAAGAGCAAUAACGAAAAAUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.